Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The small study found no evidence of delayed development of antibodies in participants who experienced rebound after taking Paxlovid.
Evusheld is used as pre-exposure prophylaxis for immunocompromised people who may not respond to COVID-19 vaccines.
Patient satisfaction surveys fail to ask whether the patients experienced discrimination or received culturally competent care.
COVID-19 vaccination was associated with a temporary average increase in menstrual cycle length of less than one day.
Biden may not have used the right word when he described the pandemic as “over,” but things are trending in the right direction.
Latinos have seen a striking decline in COVID deaths while white people account for a larger proportion.
Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.
The ruling centered on PrEP as HIV prevention but could apply to cancer screenings and other services and drugs.
Insurers should allow co-pay assistance to count as out-of-pocket spending, claims HHS lawsuit by HIV, hepatitis and diabetes advocates.
Higher levels of viral antigens in the blood correlated with more severe disease.
After mishandling COVID-19 and monkeypox, the Centers for Disease Control and Prevention aims to change—with help from Mary Wakefield.
A federal lawsuit heard last month could upend or even eliminate the preventive care requirement in the law, known as Obamacare or the ACA.
Whether omicron coronavirus variants cause long COVID symptoms as often—and as severe—as previous variants is a matter of heated study.
Samples collected from sewage water suggest viral activity is higher than the number of reported cases suggests.
An experimental vaccine produced an immune response to a range of different coronaviruses in mice and monkeys, including SARS-CoV-2.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.